Navigation Links
Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
Date:2/19/2009

> Information on patent litigation relating to 3TC can be found in our filing with the SEC on our Annual Report on Form 10-K for the year to December 31, 2007.

ZEFFIX - Chronic hepatitis B infection

Royalties from sales of ZEFFIX for the year to December 31, 2008 were $40.3 million, a decrease of 2% compared to the same period in 2007 (2007: $41.0 million). On a constant exchange rate basis, royalties from sales of ZEFFIX fell 8%.

OTHER

Other royalties are primarily in respect of REMINYL and REMINYL XL (known as RAZADYNE and RAZADYNE ER in the US), for the symptomatic treatment of mild to moderately severe dementia of the Alzheimer's type. The range is marketed worldwide (excluding the UK and the Republic of Ireland where Shire has exclusive marketing rights) by Janssen Pharmaceutical N.V., an affiliate of Johnson & Johnson.

Sales of the REMINYL/RAZADYNE range continue to grow in most countries, however the entry of generic versions of RAZADYNE and RAZADYNE ER into the US market has significantly decreased sales in that region. This decline was expected and is included in our forecasts.

Information on the RAZADYNE patent litigation (which rendered the relevant patent invalid in August 2008) and RAZADYNE ER patent litigation (which is ongoing) can be found in our filings with the SEC in our Annual Report on Form 10-K for the year to December 31, 2007 and in our Quarterly Report on Form 10-Q for the period ended September 30, 2008.

    4. Financial details
    Cost of product sales

                                      2008         % of      2007      % of
                                                product             product
                                        $m        sales        $m     sales
                                 _________    _________ _________ _________
    Cost of product sales
     (US GAAP)                      
'/>"/>
SOURCE  Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 

Related biology technology :

1. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
2. Shire plc: Change to Directors Details
3. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
4. Shires New Product Portfolio Delivers Strong Quarterly Performance
5. Change of Name to Shire plc
6. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
7. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
8. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
9. Shire Ltd.: Robin Buchanan to Step Down as Non-Executive Director on Completion of Term of Office
10. Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008
11. Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Miami, FL (PRWEB) June 17, 2013 As ... Action are committed to finding a cure all for acne, ... Month, the AARS (Acne and Rosacea Society) ... skin conditions, and helping to educate the public on treatment ... leading society by announcing their daily news updates via social ...
(Date:6/17/2013)... 17, 2013 /PRNewswire-iReach/ -- The latest research on stuttering ... to explore the neurophysiological nature of stuttering, its connection ... such as bullying and teasing. (Photo: ... their latest findings at the National Stuttering Association,s 2013 ... More than 75 speech professionals and researchers ...
(Date:6/17/2013)... The ALS Therapy Development Institute (ALS TDI) will hold ... event on July 19-21, 2013. The Tri-State Trek is a three-day, ... to Greenwich, CT with the mission to ... disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) ... passes through 46 communities and includes 12 rest stops, ...
(Date:6/17/2013)... June 17, 2013 Yongye International, Inc. (NASDAQ: ... manufacturer, and distributor of crop nutrient products in ... announced today that its common stock will resume trading ... 2013 at 7:15 a.m. Eastern Time. As ... on Monday, March 18, 2013 following Yongye,s notification that ...
Breaking Biology Technology:Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions 2New Research On Stuttering Jul 2-3 At Arizona Symposium 2New Research On Stuttering Jul 2-3 At Arizona Symposium 3ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 2ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4
... a new study conducted at the Pennington Biomedical Research Center, ... over the past fifty years is a significant contributor to ... intake cannot solely account for observed trends in weight gain ... The study, entitled "Trends Over 5 Decades in U.S. ...
... Rules-Based Medicine (RBM), a global leader in biomarker ... achieved a significant milestone in a companion diagnostic ... Roche clinical trial, the RBM DiscoveryMAP® platform, and ... was identified that has utility in prognosis of ...
... May 25, 2011 WaferGen Biosystems, Inc. (OTCBB:WGBS), ... today announced it has entered into definitive agreements ... Point Partners, LLC, Deerfield Management and Merlin Nexus, ... in a $30.4 million private placement financing of ...
Cached Biology Technology:Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 2Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 3Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche 2WaferGen Announces $30 Million Financing 2WaferGen Announces $30 Million Financing 3WaferGen Announces $30 Million Financing 4
(Date:6/17/2013)... the topics under discussion during the E3 Forum, ... consecutive year, this will be a unique event ... members of Academy, Business, Educators, Entrepreneurs, Innovators, Policy-makers ... Martn Garijo (IBM South Europe), Chris Zegras (MIT), ... (Hovione), among others. E3 Forum - Education, Employment ...
(Date:6/16/2013)... sex workers in India reduce rates of syphilis, HIV ... Toronto study has found. , About two ... southern states of Andhra Pradesh, Karnataka, Maharashtra and Tamil ... U of T,s Dalla Lana School of Public Health ... (CGHR), examined the impact of prevention among female sex ...
(Date:6/15/2013)... in Europe to treat osteoporosis has now been shown ... in cancers that have become resistant to current targeted ... The findings, presented June 15, 2013, at the annual ... drug bazedoxifene packs a powerful one-two punch that not ... but also flags the estrogen receptor for destruction. , ...
Breaking Biology News(10 mins):'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2HIV prevention among female sex workers in India reduces HIV and syphilis 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... Institut de recherches cliniques de Montréal (IRCM) have ... determines susceptibility to candidiasis, a common and often ... immunodeficiency virus (HIV). These findings, revealed using a ... developed by the same research group, represents a ...
... at the University of York have made a huge leap ... research group in the Department of Biology has made a ... a type of biological warfare. , Bacteria like E. coli ... using protein antibiotics called colicins, which are potent toxins. ...
... has developed a small, relatively inexpensive "seeing machine" that ... like her, to access the Internet, view the face ... Recently the machine received positive feedback from 10 visually ... vision loss who tested it in a pilot clinical ...
Cached Biology News:Montreal researchers identify defects of immune cells 2MIT 'seeing machine' offers hope to blind 2MIT 'seeing machine' offers hope to blind 3MIT 'seeing machine' offers hope to blind 4
MOUSE ANTI HUMAN C-MYC aa171-188...
MOUSE ANTI SIMIAN VIRUS 5 Immunogen: Simian virus 5...
ANTI ALPHA FSH:B...
... Serum • Beagle serum is collected from ... year of age Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium ... Alsevers N-05: ACD N-07: ...
Biology Products: